Our study showed that levels of several autoantibodies to nervous system epitopes were associated with the clinical severity of COVID-19, including IgG antibodies to the dopamine 1 receptor, NMDA receptors, brain-derived neurotrophic factor (BNDF), and myelin oligodendrocyte glycoprotein. This evidence concerns the gene MOG and COVID-19.